Nathan Lee

PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models

Helen Y. Zou, Luc Friboulet, David P. Kodack et al. · Cancer Cell · 2015 · 456 citations · Full text

Drug Target, Health Sciences, Preclinical Models +10

A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro

Janet Myungjin Lee, Paulette Mhawech‐Fauceglia, Nathan Lee et al. · Laboratory Investigation · 2013 · 301 citations

Three-dimensional Microenvironment Alters, Medicine, Biological Microenvironments +10

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 172 citations

Tumor Biology, Oncology, Cdk2/4/6 Inhibitor +10

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

Jennifer Permuth‐Wey, Kate Lawrenson, Howard C. Shen et al. · Nature Communications · 2013 · 108 citations · Full text

MicroRNA-615-5p Regulates Angiogenesis and Tissue Repair by Targeting AKT/eNOS (Protein Kinase B/Endothelial Nitric Oxide Synthase) Signaling in Endothelial Cells

Basak Icli, Winona Wu, Denizhan Ozdemir et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 99 citations · Full text

Endothelial Cells, Nitric Oxide, Immunology +18